FDA Identifies 20 Drugs With Shortage Risks Due to Coronavirus Outbreak
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Jan. 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via Reuters
The U.S. Food and Drug Administration has contacted producers of about 20 drugs that either source all of their main ingredients from or are finished in China to gauge if they will face shortages due to the coronavirus outbreak.
None of the companies reported that a shortage is expected for their drugs due to the outbreak, an FDA spokeswoman said.
